Leveraging AI for drug treatments, stock investments, revolutionizing metabolic MRIs with polarizers, and more. $250M: AI Drug Discovery Collaboration XtalPi Inc. announced an AI drug discovery collaboration of up to $250 million in upfront and milestone payments with Eli Lilly and Company. The collaboration will leverage XtalPi’s integrated AI capabilities and robotics platform to de […]
